Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 1 376.55 INR 0.7% Market Closed
Market Cap: 246.6B INR
Have any thoughts about
Natco Pharma Ltd?
Write Note

Natco Pharma Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Natco Pharma Ltd
Total Equity Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Natco Pharma Ltd
NSE:NATCOPHARM
Total Equity
â‚ą58.5B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
23%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Equity
â‚ą282.5B
CAGR 3-Years
17%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Equity
â‚ą283.6B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Equity
â‚ą691.1B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
12%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Equity
â‚ą75B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
12%
M
Mankind Pharma Ltd
NSE:MANKIND
Total Equity
â‚ą93.6B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Natco Pharma Ltd's Total Equity?
Total Equity
58.5B INR

Based on the financial report for Jun 30, 2024, Natco Pharma Ltd's Total Equity amounts to 58.5B INR.

What is Natco Pharma Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
23%

Over the last year, the Total Equity growth was 20%. The average annual Total Equity growth rates for Natco Pharma Ltd have been 12% over the past three years , 11% over the past five years , and 23% over the past ten years .

Back to Top